JP2002536438A5 - - Google Patents

Download PDF

Info

Publication number
JP2002536438A5
JP2002536438A5 JP2000598485A JP2000598485A JP2002536438A5 JP 2002536438 A5 JP2002536438 A5 JP 2002536438A5 JP 2000598485 A JP2000598485 A JP 2000598485A JP 2000598485 A JP2000598485 A JP 2000598485A JP 2002536438 A5 JP2002536438 A5 JP 2002536438A5
Authority
JP
Japan
Prior art keywords
alkyl
residue
aryl
cycloalkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000598485A
Other languages
English (en)
Japanese (ja)
Other versions
JP4642242B2 (ja
JP2002536438A (ja
Filing date
Publication date
Priority claimed from EP99102916A external-priority patent/EP1028114A1/en
Application filed filed Critical
Publication of JP2002536438A publication Critical patent/JP2002536438A/ja
Publication of JP2002536438A5 publication Critical patent/JP2002536438A5/ja
Application granted granted Critical
Publication of JP4642242B2 publication Critical patent/JP4642242B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000598485A 1999-02-13 2000-02-04 細胞接着の阻害剤としての新規のグアニジン誘導体 Expired - Lifetime JP4642242B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99102916A EP1028114A1 (en) 1999-02-13 1999-02-13 Novel guanidine derivatives as inhibitors of cell adhesion
EP99102916.6 1999-02-13
PCT/EP2000/000895 WO2000047564A1 (en) 1999-02-13 2000-02-04 Novel guanidine derivatives as inhibitors of cell adhesion

Publications (3)

Publication Number Publication Date
JP2002536438A JP2002536438A (ja) 2002-10-29
JP2002536438A5 true JP2002536438A5 (cg-RX-API-DMAC7.html) 2007-01-11
JP4642242B2 JP4642242B2 (ja) 2011-03-02

Family

ID=8237555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000598485A Expired - Lifetime JP4642242B2 (ja) 1999-02-13 2000-02-04 細胞接着の阻害剤としての新規のグアニジン誘導体

Country Status (11)

Country Link
US (1) US6340679B1 (cg-RX-API-DMAC7.html)
EP (2) EP1028114A1 (cg-RX-API-DMAC7.html)
JP (1) JP4642242B2 (cg-RX-API-DMAC7.html)
AT (1) ATE273285T1 (cg-RX-API-DMAC7.html)
AU (1) AU768206B2 (cg-RX-API-DMAC7.html)
CA (1) CA2371789C (cg-RX-API-DMAC7.html)
DE (1) DE60012890T2 (cg-RX-API-DMAC7.html)
ES (1) ES2225086T3 (cg-RX-API-DMAC7.html)
IL (1) IL144725A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA01008072A (cg-RX-API-DMAC7.html)
WO (1) WO2000047564A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19629816A1 (de) * 1996-07-24 1998-01-29 Hoechst Ag Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
US6972296B2 (en) 1999-05-07 2005-12-06 Encysive Pharmaceuticals Inc. Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
ES2270868T3 (es) 1999-08-13 2007-04-16 Biogen Idec Ma Inc. Inhibidores de la adhesion celular.
KR20040058229A (ko) 2001-10-22 2004-07-03 더 스크립스 리서치 인스티튜트 항체 표적화 화합물
AU2004287875B2 (en) 2003-11-05 2011-06-02 Bausch + Lomb Ireland Limited Modulators of cellular adhesion
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
SI1881823T1 (sl) * 2005-05-17 2015-04-30 Sarcode Bioscience Inc. Sestavki in postopki za zdravljenje bolezni oäśesa
WO2007048127A2 (en) * 2005-10-20 2007-04-26 The Scripps Research Institute Fc labeling for immunostaining and immunotargeting
CA2702984C (en) 2007-10-19 2017-04-11 Sarcode Corporation Compositions and methods for treatment of diabetic retinopathy
EP3632444A3 (en) * 2008-04-15 2020-08-26 SARcode Bioscience Inc. Topical lfa-1 antagonists for use in localized treatment of immune related disorders
WO2009139817A2 (en) * 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
CN102065694A (zh) * 2008-04-15 2011-05-18 萨可德公司 用于局部治疗免疫相关疾病的雾化的lfa-1拮抗剂
EP2276508A4 (en) * 2008-04-15 2011-12-28 Sarcode Bioscience Inc ADMINISTRATION OF LFA-1 ANTAGONISTS TO THE GASTROINTESTINAL SYSTEM
JP2012517447A (ja) 2009-02-10 2012-08-02 ザ スクリプス リサーチ インスティチュート 化学的にプログラムされたワクチン接種法
US8378105B2 (en) * 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
EP2877465A4 (en) 2012-07-25 2016-05-11 Sarcode Bioscience Inc LFA-1 HEMMER AND POLYMORPH THEREOF

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204350A (en) 1991-08-09 1993-04-20 Merck & Co., Inc. Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives
US5217994A (en) 1991-08-09 1993-06-08 Merck & Co., Inc. Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives
US5250679A (en) 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
EP0667773A4 (en) 1992-10-14 1996-09-25 Merck & Co Inc FIBRINOGEN RECEPTOR ANTAGONISTS.
CA2150550A1 (en) 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
ATE227567T1 (de) 1994-05-27 2002-11-15 Merck & Co Inc Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
ZA955391B (en) 1994-06-29 1996-02-09 Smithkline Beecham Corp Vitronectin receptor antagonists
WO1996000730A1 (en) 1994-06-29 1996-01-11 Smithkline Beecham Corporation Vitronectin receptor antagonists
CA2227265C (en) 1995-08-14 2012-01-03 The Scripps Research Institute Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
DE19548709A1 (de) * 1995-12-23 1997-07-03 Merck Patent Gmbh Tyrosinderivate
EP0907637A1 (de) * 1996-06-28 1999-04-14 MERCK PATENT GmbH Phenylalanin-derivate als integrin-inhibitoren
DE19629816A1 (de) * 1996-07-24 1998-01-29 Hoechst Ag Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
EP0933367A1 (en) * 1997-12-19 1999-08-04 Hoechst Marion Roussel Deutschland GmbH Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists
BR9907735A (pt) 1998-01-23 2000-10-17 Aventis Pharma Gmbh Derivados de sulfonamida como inibidores da reabsorção óssea e como inibidores da aderência celular

Similar Documents

Publication Publication Date Title
JP2001526271A5 (cg-RX-API-DMAC7.html)
JP2002501054A5 (cg-RX-API-DMAC7.html)
JP2022545359A5 (cg-RX-API-DMAC7.html)
JP2002515500A5 (cg-RX-API-DMAC7.html)
HU229700B1 (en) Calcium salt of (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl)sulfonyl]-(isobutyl)amino]-1-benzyl-2-(phosphonooxy) propylcarbamate, pharmaceutical composition containing the compound and process for preparation the same
PL192779B1 (pl) Zastosowanie N-podstawionych indolo-3-glioksyloamidów
JP4596314B2 (ja) β−アラニン誘導体およびその用途
JP2024510939A5 (cg-RX-API-DMAC7.html)
JP2002525323A5 (cg-RX-API-DMAC7.html)
JP2022539126A (ja) ベンゾジアゼピン系化合物及びその製造方法並びに医薬における作用
JP2003519137A (ja) 抗腫瘍作用を有する置換されたn−ベンジル−インドール−3−イルグリオキシル酸誘導体
JPH02255652A (ja) ベンゼンスルホンアミド類およびその製造方法
JP2003513066A5 (cg-RX-API-DMAC7.html)
JP2005516898A5 (cg-RX-API-DMAC7.html)
JP2003514859A5 (cg-RX-API-DMAC7.html)
JP3199736B2 (ja) アミノアルキル置換された2−アミノ−5−メルカプトチアジアゾール、その製造及び使用
RU2005105688A (ru) Полиморфизм додекагидроциклопента (а) фенантренилового эфира тиофенкарбоновой кислоты
WO2003024946A2 (en) Oxamate derivatives containing a variously substituted nitrogen heterocycle
ZA200704584B (en) New 3-Phenylpropionic acid derivatives for the treatment of diabetes
JP2002503721A5 (cg-RX-API-DMAC7.html)
JP2005515169A5 (cg-RX-API-DMAC7.html)
JP2002530403A5 (cg-RX-API-DMAC7.html)
RU2302413C2 (ru) Водорастворимые производные фенилпиридазина и содержащие их лекарственные средства
JP2004505084A5 (cg-RX-API-DMAC7.html)
JPWO2004083188A1 (ja) 水溶性フェニルピリダジン誘導体及びこれを含有する医薬